Ligand Pharmaceuticals | LGND - 销售收入



金融业
股票价格
USD
资产
USD 1.53B
现金及等价物
USD 115.08M
销售成本
USD 11.37M
流动资产
USD 865.42M
流动负债
USD 40.67M
债务
USD 451.49M
EBIT
USD 60.33M
EBITDA
USD 66.78M
员工
68
EPS每股收益
USD 1.63
股本和储备
USD 997.32M
销售毛利
USD 48.45M
债务利息支出
USD 1.79M
利息收入
USD 6.39M
贷款资金
USD 446.19M
市值
USD 5.52B
净收入
USD -13.35M
营业费用
USD 34.35M
营业利润
USD 60.33M
普通股股本
USD 19.66M
PE价格收益
56.5
税前利润
USD 56.78M
销售收入
USD 51.72M
销售和管理费用
USD 20.84M
股票
USD 13.27M
贸易债权人
USD 37.11M
应收帐款人
USD 54.8M


销售 更改 日
Agenus USD 33.7M 500K 2026-03
Amgen USD 8.62B 1.28B 2026-03
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 73.74M 190.29M 2026-03
Baxter International USD 2.7B 270M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
Enviri Corporation USD 555M 19.81M 2025-12
Gilead Sciences USD 7B 930M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
Glaxosmithkline GBP 10.09B 1.37B 2026-03
Heron Therapeutics USD 40.59M 2.38M 2025-12
Insmed USD 305.96M 42.16M 2026-03
Intrexon USD 717K 511K 2024-06
Ionis Pharmaceuticals USD 246M 43M 2026-03
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Ligand Pharmaceuticals USD 51.72M 7.94M 2026-03
MacroGenics USD 20.8M 20.43M 2026-03
Merck USD 16.29B 110M 2026-03
Pacira USD 177M 19.87M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Sangamo BioSciences USD 356K 125K 2024-06
Veracyte USD 139.07M 1.53M 2026-03